Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
KINNATE BIOPHARMA INC
About KNTE
Kinnate Biopharma Inc. is a clinical-stage precision oncology company. It is focused on the discovery, design and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. Its lead product candidate is exarafenib (KIN-2787), which is a Rapidly Accelerated Fibrosarcoma (RAF) inhibitor in development for the treatment of patients with lung cancer, melanoma and other solid tumors. Its second product candidate is KIN-3248, a Fibroblast Growth Factor Receptors (FGFR) inhibitor, designed for the treatment of patients with intrahepatic cholangiocarcinoma (ICC). KIN-3248 is designed to address clinically observed kinase domain mutations in FGFR2 and FGFR3. It is also advancing other small molecule research programs, including a Cyclin-Dependent Kinase 12 (CDK12) inhibitor in its KIN004 program for the treatment of ovarian carcinoma (OC), triple-negative breast cancer (TNBC) and metastatic castration-resistant prostate cancer (mCRPC).
Find out what a historical investment in KINNATE BIOPHARMA INC would be worth today using our KNTE stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy KNTE shares in Australia?
Buying KNTE shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in KINNATE BIOPHARMA INC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in KNTE
What is the ticker symbol of KINNATE BIOPHARMA INC?
The ticker symbol for KINNATE BIOPHARMA INC is KNTE.
How much is one share of KNTE?
One share of KNTE is valued at $2.65 as of 20 May 2026.
What is the market capitalisation of KINNATE BIOPHARMA INC KNTE?
As of 20 May 2026 KINNATE BIOPHARMA INC has a market cap of -.
What is the 52-week high for KINNATE BIOPHARMA INC stock?
The KINNATE BIOPHARMA INC 52-week high stock price is $NaN.
What is the 52-week low for KINNATE BIOPHARMA INC stock?
The KINNATE BIOPHARMA INC 52-week low stock price is $NaN.
Can I buy KNTE shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy KNTE shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in KNTE on Stake
- Buy KNTE from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of KNTE from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
KNTE related stocks